Anthos Therapeutics Shares New Data from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Significantly Reduced Bleeding in Patients Regardless of Age or Bleeding Risk
--Data presented at the American College of Cardiology Annual Scientific Session show…
Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025
- The late-breaking oral presentation at SGO 2025 highlights consistent response rates…
Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients
PALMA DE MALLORCA, Spain, March 5, 2025 /PRNewswire/ -- Laminar Pharma, a leader…
Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
March 03, 2025 09:27 ET | Source: Pliant Therapeutics, Inc. SOUTH SAN…
Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025
March 01, 2025 12:45 ET | Source: Celldex Therapeutics, Inc. - Greatly…
Vantage Foundation Brings Hope and Support to Patients at National Burn Hospital, Hanoi
HANOI, Vietnam, Feb. 24, 2025 /PRNewswire/ -- Vantage Foundation proudly announces its partnership…
REPEAT/MEDIA ADVISORY – Patients who have been extra-billed for surgeries in private for-profit clinics demand accountability in the Ontario election: Press conferences in towns across Ontario
February 15, 2025 08:00 ET | Source: Ontario Health Coalition TORONTO, OTTAWA,…
UPDATE: Coalition of Groups Representing Tens of Millions of Patients Calls for Protection of the Nations Vital Health Infrastructure
February 14, 2025 19:15 ET | Source:
Coalition of Groups Representing Tens of Millions of Patients Calls for Protection of the Nations Vital Health Infrastructure
February 14, 2025 18:20 ET | Source:
TriNetX and Fujitsu Launch Joint Venture to Increase Japanese Patients’ Access to Life-Changing Medicines
Partnership taps real-world data to accelerate clinical trials, research, and drug development…